Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Objective

To compare the effects of transperitoneal and retroperitoneal approaches for robotic assisted partial nephrectomy (RAPN) in patients with renal cell carcinoma (RCC).

Methods

We conducted a retrospective cohort study on RAPN at Affiliated Hospital of Jiangsu University. Between September 2020 and February 2024, the included patients underwent either transperitoneal approach or retroperitoneal approach. Perioperative status, stress response, quality of life, and incidence of complications were compared between the groups.

Results

A total of 105 patients were included in this analysis, with 54 patients in the Retroperitoneal group, and 51 patients in the Transperitoneal group. The retroperitoneal approach was associated with significantly better perioperative indicators compared to the transperitoneal method (P<0.05). After the surgery, serum levels of interleukin-6 (IL-6), C-reactive protein (CRP), white blood cell count (WBC), and cortisol (Cor) in the Retroperitoneal group were lower than in the Transperitoneal group (P<0.05). The quality-of-life scores of patients in the Retroperitoneal group were higher (P<0.05), but no statistically significant difference in the incidence of complications between the groups (P>0.05).

Conclusions

Compared with the transperitoneal approach, the retroperitoneal method of RAPN is equally safe and is associated with improved perioperative status, lower stress response, and better quality of life for RCC patients.

Free full text 


Logo of pakjmedsciLink to Publisher's site
Pak J Med Sci. 2024 Nov; 40(10): 2202–2207.
PMCID: PMC11568722
PMID: 39554681

Comparison of the effects of transperitoneal and retroperitoneal robot-assisted partial nephrectomy

Abstract

Objective:

To compare the effects of transperitoneal and retroperitoneal approaches for robotic assisted partial nephrectomy (RAPN) in patients with renal cell carcinoma (RCC).

Methods:

We conducted a retrospective cohort study on RAPN at Affiliated Hospital of Jiangsu University. Between September 2020 and February 2024, the included patients underwent either transperitoneal approach or retroperitoneal approach. Perioperative status, stress response, quality of life, and incidence of complications were compared between the groups.

Results:

A total of 105 patients were included in this analysis, with 54 patients in the Retroperitoneal group, and 51 patients in the Transperitoneal group. The retroperitoneal approach was associated with significantly better perioperative indicators compared to the transperitoneal method (P<0.05). After the surgery, serum levels of interleukin-6 (IL-6), C-reactive protein (CRP), white blood cell count (WBC), and cortisol (Cor) in the Retroperitoneal group were lower than in the Transperitoneal group (P<0.05). The quality-of-life scores of patients in the Retroperitoneal group were higher (P<0.05), but no statistically significant difference in the incidence of complications between the groups (P>0.05).

Conclusions:

Compared with the transperitoneal approach, the retroperitoneal method of RAPN is equally safe and is associated with improved perioperative status, lower stress response, and better quality of life for RCC patients.

KEYWORDS: Robot-assisted partial nephrectomy, Renal cell carcinoma, Retroperitoneal, Transperitoneal

INTRODUCTION

Renal cell carcinoma (RCC) originates from the renal epithelium, and accounts for over 90% of all kidney cancers.1,2 Surgical intervention is the preferred treatment for early and mid-stage RCC and is associated with good clinical outcomes and no need for subsequent chemotherapy or radiation therapy.3-5 However, the effects of different surgical approaches and of zero ischaemia on the postoperative reduction in renal function remain controversial. We aimed to investigate the relative short- and long-term changes in estimated glomerular filtration rate (eGFR However, traditional open surgery is accompanied by significant trauma.6,7 Recently, laparoscopic and robot-assisted laparoscopic minimally invasive surgeries have gained popularity due to minimal trauma and a good prognosis. Studies show that robotic-assisted partial nephrectomy (RAPN) can reduce the trauma caused by invasive surgery and improve the effectiveness and safety of treatment by using anatomical structures as markers for surgical treatment.4-8

Currently, RAPN can be done with either a transperitoneal or retroperitoneal approach. While the transperitoneal approach allows for increased manipulating space for the devices, the retroperitoneal approach is performed in smaller retroperitoneal space and, therefore, requires more extensive training. However, this approach is associated with lower gastrointestinal complications and urine leaks outside of the peritoneum.5-9 Currently, there is still no consensus on which is the most efficient RAPN approach. These two approaches have similar postoperative, functional, and oncological outcomes for patients with posterolateral renal tumors, although the retroperitoneal approach has shorter operative time. However, a meta-analysis by Zhou J et al.10 and a most recent meta-analysis by Shrivastava N11 reported that the retroperitoneal approach is superior to the transperitoneal approach in terms of operative time, estimated blood loss, and postoperative length of hospital stay. Even so, Zhou’s report did not show any significant differences in perioperative complications while Shrivastava’s report showed a significantly lower complication rate for the retroperitoneal approach. This study aimed to retrospectively analyze the clinical data of RCC patients of the Affiliated Hospital of Jiangsu University to clarify the application effects of different RAPN approaches in patients with RCC.

METHODS

Clinical records of patients who underwent RAPN at the Affiliated Hospital of Jiangsu University from September 2020 to February 2024 were retrospectively analyzed in this retrospective study. According to the different surgical approaches, patients were stratified into two groups: Transperitoneal group and Retroperitoneal group.

Inclusion & Exclusion Criteria:

Patients diagnosed with unilateral RCC12 and undergoing RAPN surgery were included. Patients with history of drug and alcohol dependence, abnormal coagulation function, systemic infectious diseases, cardiovascular and cerebrovascular diseases, blood system diseases, or incomplete data were excluded. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Ethical Approval:

This study was approved by the Ethics Review Board of Affiliated Hospital of Jiangsu University (No. LZ2024046; April 23, 2024).

Surgical procedures:

The procedures were performed by the same group of experienced surgeons.

(1)Retroperitoneal approach:

The procedure was performed using the da Vinci surgical robot system. Computed tomography (CT) and arterial CT-enhanced angiography were performed before the surgery, and the anatomical location and volume of the tumor and blood vessels were determined through three-dimensional reconstruction. Under general anesthesia, the lumbar bridge was elevated appropriately, and the patient was placed on the healthy side. Retroperitoneal space was dilated, with the first puncture point located approximately 2cm below the rib margin of the midaxillary line. Blunt separation of the subcutaneous muscle layer and lumbar fascia layer was performed using vascular forceps.

The peritoneum was separated using the index finger. For overweight patients, an airbag was placed in the retroperitoneal space, and 600 ml of gas was injected. After about five minutes, the gas inside the airbag was discharged. For patients with normal weight, the index finger was inserted and used as a guide to make the second puncture point on the skin about 1cm below the axillary line. The third puncture point was made 2cm above the iliac crest. Trocar was inserted, and a 10mm incision was made in the midaxillary line. After inserting a cannula, suturing was performed. Gas was injected and the pressure value was maintained at 15 mmHg. An observation mirror was inserted into the casing. Assisted by laparoscopy, the surgical procedure was performed to clarify the peritoneal fold and lumbar muscle anatomy upon reaching the abdominal cavity.

The perirenal fascia was opened near the peritoneal fold, and ureteral dissociation was performed at a distance of 2cm from the upper/lower pole of the kidney. The kidney was released along the psoas major muscle. After clarifying the location of the renal artery, the surrounding tissues were separated layer by layer, and the ventral renal pedicle was freed. If the operating area was narrow, the kidney was gently rotated and freed to fully expose the diseased tissue. Renal blood vessels were clumped, and the diseased tissue was removed together with the 0.5-1 cm margin. A catheter was placed for drainage, the incision was closed, and the remaining fat on the surface of the kidney was fixed to the surrounding tissue using a Hem-o-lok clamp, restoring the anatomical position of the kidney.

Transperitoneal approach:

Patients were placed in a healthy lateral position, and a 1cm incision was made next to the navel. A pneumoperitoneum needle was inserted, an artificial pneumoperitoneum was constructed and placed by laparoscopy. The laparoscopic-assisted incision was made at the level of the iliac crest and umbilicus, as well as approximately 2cm below the outer rib margin of the rectus abdominis muscle, and a trocar was inserted. The incision raised and lowered the para colon sulcus, and the colon and mesentery were released downwards. The remaining procedures were similar to the retroperitoneal approach.

Observation indicators:

  • Perioperative conditions, including surgical duration, intraoperative blood loss, postoperative ventilation duration, start of food intake, and length of hospital stay.

  • Stress response indicators, including levels of interleukin-6 (IL-6), C-reactive protein (CRP), white blood cell count (WBC), and cortisol (Cor), were measured in the 2ml of fasting venous blood by enzyme-linked immunosorbent assay.

  • Quality of life: The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) was used to evaluate cognitive, social, emotional, and physical functions.13 The score range for each dimension was 0-100 points, and the higher the score, the better the quality of life.

  • Complications, including renal dysfunction, hematuria, subcutaneous edema, and infection.

Statistical Analysis:

All data analyses were conducted according to predefined statistical analysis plans using SPSS version 25.0 software (IBM, Armonk, New York, USA). For continuous variables, the means and standard deviations (SD) were calculated. The independent sample t-test was used to compare the mean of two independent samples, especially for continuous variables. The hypothesis of equal variance was examined and considered in the analysis. For categorical variables, frequency distribution was provided and expressed as a percentage. The chi square test was used to compare categorical variables, such as gender distribution and tumor location, between two groups. A p-value less than 0.05 was considered statistically significant.

RESULTS

Clinical records of 122 patients with RAPN were considered for this retrospective study. Of them, 105 patients (71 males and 34 females) met eligibility criteria. There were 54 cases in the Retroperitoneal group and 51 cases in the Transperitoneal group (Fig.1), with no statistically significant difference in general information between the two groups of patients (P>0.05) (Table-I).

An external file that holds a picture, illustration, etc.
Object name is PJMS-40-2202-g001.jpg

Guidelines Flow Diagram.

Table-I

Comparison of General Information between Two Groups.

ItemRetroperitoneal group (n=54)Transperitoneal roup (n=51)t/χ2P
Gender [n (%)]
Male35 (64.81)36 (70.59)0.3990.527
Female19 (35.19)15 (29.41)
Age (year)50.15±6.3848.92±7.910.8790.381
Lesion diameter (cm)3.78±0.913.92±0.860.8090.420
Affected side [n (%)]
Left29 (53.70)25 (49.02)0.2300.631
Right25 (46.30)26 (50.98)
BMI (kg/m2)23.47±2.5923.73±2.390.5340.595
Tumor location [n (%)]
Upper pole37 (68.52)36 (70.59)0.0540.974
Middle pole9 (16.67)8 (15.69)
Lower pole8 (14.81)7 (13.73)

The duration of surgery, postoperative ventilation, start of ingestion, and length of hospital stay in the Retroperitoneal group were shorter, and the intraoperative blood loss was lower than in the Transperitoneal group (P<0.05) (Fig.2).

An external file that holds a picture, illustration, etc.
Object name is PJMS-40-2202-g002.jpg

Comparison of perioperative conditions between two groups.

Before the surgery, there was no significant difference in serum levels of IL-6, CRP, WBC, and Cor in both groups (P>0.05). After surgery, serum levels of IL-6, CRP, WBC, and Cor in both groups increased but were significantly lower in the Retroperitoneal group compared to the Transperitoneal group (P<0.05) (Fig.3).

An external file that holds a picture, illustration, etc.
Object name is PJMS-40-2202-g003.jpg

Comparison of stress response index levels between two groups; Compared with the same group before surgery, aP<0.05; Compared to Transperitoneal group, bP<0.05; IL-6: interleukin-6; CRP: C-reactive protein; WBC: white blood cell count; Cor: cortisol.

Pre-surgery EORTC QLQ-C30 scores of cognitive, social, emotional, and physical functioning were comparable in both groups (P>0.05). After the surgery, all EORTC QLQ-C30 scores in both groups increased and were considerably higher in the Retroperitoneal group compared to the Transperitoneal group (P<0.05) (Fig.4). There was no statistically significant difference in the incidence rate of complications between the two groups (P>0.05) (Table-II).

An external file that holds a picture, illustration, etc.
Object name is PJMS-40-2202-g004.jpg

Comparison of Quality of Life between Two Groups.

Table-II

Comparison of incidence rates of complications between two groups.

GroupnAbnormal renal functionHematuriaSubcutaneous edemaInfectTotal incidence rate
Retroperitoneal group540 (0.00)1 (1.85)1 (1.85)0 (0.00)2 (3.70)
Transperitoneal group512 (3.92)2 (3.92)3 (5.88)1 (1.96)8 (15.69)
χ2 3.090
P 0.079

DISCUSSION

This study retrospectively analyzed the clinical data of 105 RCC patients who underwent RAPN. The results showed that the retroperitoneal RAPN approach was associated with lower surgical duration and postoperative ventilation time, quicker start of feeding, shorter hospital stay, and lower intraoperative blood loss compared to the transperitoneal approach. The retroperitoneal RAPN was also linked to lower stress response and considerably better quality of life than the transperitoneal approach.

Both retroperitoneal and transperitoneal RAPN are important clinical treatments for RCC.11,14 Similar with Shrivastava N11, a study by Liao XH et al.14 that included RCC patients with ≥ T1b stage found that retroperitoneal laparoscopic total renal artery occlusion can effectively protect renal function without increasing intraoperative blood loss and the risk of postoperative complications. A propensity score-matched comparative analysis by Takagi T et al.15 also demonstrated that compared to the transperitoneal approach, the retroperitoneal method has significant advantages in terms of surgical time, estimated blood loss and postoperative length of hospital stay. Lanzotti NJ et al.16 investigated the difference in the application effect of retroperitoneal and retroperitoneal approaches for radical nephrectomy in RCC patients and also confirmed that the retroperitoneal approach could reduce surgical trauma and lower the risk of complications. In contrast, the study by Tang H17 showed that in RCC patients, both transperitoneal and retroperitoneal approaches were associated with similar surgical time, renal artery occlusion time, intraoperative blood loss, positive surgical margin rate, and incidence of postoperative complications. Their study only reported shorter postoperative recovery time for intestinal function in patients who underwent retroperitoneal RAPN compared to transperitoneal surgery.17 The results of this present study are generally consistent with those previous studies by Shrivastava N11, Liao XH et al.14, Takagi T et al.15, and Lanzotti NJ et al.16, except with regard to incidence rate of complications. This discrepancy may be related to the different populations, disease stages, severity of the selected cases, and sample size.

The transperitoneal approach requires inserting the instruments into the abdominal cavity, which has the advantages of an obvious anatomical position and large operating space. Therefore, this approach is convenient for the treatment of large-volume tumors and makes it easier to address injuries that may occur during the surgery.10,18,19 However, during the surgery, it is necessary to separate the peritoneum and organize the intestinal mesentery, which can easily lead to complications such as intestinal obstruction and paralysis. Moreover, exposing tumor tissue takes a long time, which may negatively impact postoperative eating and recovery times.18,19

The retroperitoneal approach, which involves mechanical insertion into the abdominal cavity through the retroperitoneum, allows to obtain a faster surgical field of view and requires less free peritoneum and mesentery.19,20 Therefore, this method is associated with shorter surgical time, as well as time for postoperative food intake and faster recovery. However, retroperitoneal access results in a narrower surgical field of view, which makes identifying the anatomical landmarks more difficult and, therefore, requires extensive training.20-22

Our results also reported that the retroperitoneal approach was associated with a significantly lower stress response, as indicated by lower serum levels of IL-6, CRP, WBC, and Cor. Furthermore, quality of life scores in patients who underwent surgery with the retroperitoneal approach were higher compared to the Transperitoneal group, while the incidence of complications was comparable. Our results further confirm the feasibility and effectiveness of the retroperitoneal RAPN for RCC.

The advantages of the retroperitoneal approach that were identified in our study and confirmed by previous research are of great clinical significance for improving the effectiveness and safety of RCC treatment. The retroperitoneal approach can reduce interference with abdominal organs, facilitate the separation, exposure, and clamping of renal blood vessels, accurately control renal pedicle blood vessels, reduce surgical trauma, improve surgical efficiency, reduce surgical treatment time, and shorten postoperative rehabilitation time.23,24

Limitations:

It is a single-center retrospective analysis with a small sample size. The cohort included in the study was not homogeneous in clinical and pathological diagnosis. The impact of the two methods on the long-term functional recovery of patients was not analyzed. The data of this study need to be confirmed through further research on expanding and specific patient cohorts. Finally, we could not eliminate the potential impact of drugs on the obtained results. Further high-quality research is needed to validate the conclusions of this study.

CONCLUSION

Compared with the transperitoneal approach, a retroperitoneal RAPN for RCC can reduce trauma, shorten postoperative recovery time, alleviate stress reactions caused by invasive surgical procedures, improve patient quality of life, and with equally safe profile.

Authors’ contributions:

MT: Conceived designed the study and Review. Was involved in preparing the manuscript.

KC, WX, ZQ and PP: Collected the data .performed the analysis and Review.

All authors have read and approved the final manuscript and are responsible for the integrity of the study.

REFERENCES

1. Boru YE, Sutcuoglu O, Caliskan K, Gocun PU, Yazici O. Renal Clear Cell Carcinoma with Unknown Primary:Is It Real Entity or Just Hypothesis? J Coll Physicians Surg Pak. 2022;32(12):SS200–SS202. 10.29271/jcpsp.2022. Supp0.SS200. [Abstract] [Google Scholar]
2. Afzal A, Kaleem A, Asghar MS, Asghar MS. Thyroid-like follicular carcinoma of kidney:Case presentation and literature review. J Pak Med Assoc. 2021;71(8):2073–2076. 10.47391/JPMA.086. [Abstract] [Google Scholar]
3. Ebbing J, Menzel F, Frumento P, Miller K, Ralla B, Fuller TF, et al. Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer. BMC Nephrol. 2019;20(1):40. 10.1186/s12882-019-1215-3. [Europe PMC free article] [Abstract] [Google Scholar]
4. Xu Y, Huang J, Fan X, Wang Z, Lou J, Liu X, et al. Clinical experience of bench surgery combined with autotransplantation after three-dimensional laparoscopic nephrectomy for the treatment of highly complex renal tumor. World J Surg Oncol. 2023;21(1):373. 10.1186/s12957-023-03246-9. [Europe PMC free article] [Abstract] [Google Scholar]
5. Gao X, Hu L, Pan Y, Zheng L. Surgical outcomes of nephrectomy for elderly patients with renal cell carcinoma. Pak J Med Sci. 2018;34(2):288–293. 10.12669/pjms.342.14062. [Europe PMC free article] [Abstract] [Google Scholar]
6. Bukavina L, Mishra K, Calaway A, Ponsky L. Robotic Partial Nephrectomy:Update on Techniques. Urol Clin North Am. 2021;48(1):81–90. 10.1016/j.ucl.2020.09.013. [Abstract] [Google Scholar]
7. Sahin S, Resorlu B, Eksi M, Aras B, Atar A, Tugcu V. Flexible ureteroscopy versus laparoscopy for the treatment of patients who initially presented with obstructive pyelonephritis. Pak J Med Sci. 2016;32(3):570–574. 10.12669/pjms.323.9938. [Europe PMC free article] [Abstract] [Google Scholar]
8. Wang H, Chen R, Li T, Peng L. Robot-assisted laparoscopic vs laparoscopic donor nephrectomy in renal transplantation:A meta-analysis. Clin Transplant. 2019;33(1):e13451. 10.1111/ctr.13451. [Abstract] [Google Scholar]
9. Abaza R, Gerhard RS, Martinez O. Feasibility of adopting retroperitoneal robotic partial nephrectomy after extensive transperitoneal experience. World J Urol. 2020;38(5):1087–1092. 10.1007/s00345-019-02935-z. [Abstract] [Google Scholar]
10. Zhou J, Liu ZH, Cao DH, Peng ZF, Song P, Yang L, et al. Retroperitoneal or transperitoneal approach in robot-assisted partial nephrectomy, which one is better? Cancer Med. 2021;10(10):3299–3308. 10.1002/cam4.3888. [Europe PMC free article] [Abstract] [Google Scholar]
11. Shrivastava N, Bhargava P, Sharma G, Choudhary GR. Transperitoneal versus retroperitoneal robot-assisted partial nephrectomy:a systematic review and meta-analysis. World J Urol. 2024;42(1):83. 10.1007/s00345-024-04796-7. [Abstract] [Google Scholar]
12. Powles T, Albiges L, Bex A, Comperat E, Grünwald V, Kanesvaran R, et al. ESMO Guidelines Committee. Electronic address:[email protected]. Renal cell carcinoma:ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(8):692–706. 10.1016/j.annonc.2024.05.537. [Abstract] [Google Scholar]
13. Cocks K, Wells JR, Johnson C, Schmidt H, Koller M, Oerlemans S, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. Eur J Cancer. 2023;178:128–138. 10.1016/j.ejca.2022.10.026. [Abstract] [Google Scholar]
14. Liao XH, An J, Su GL, Li YF, Dong Y, Yin T, et al. Efficacy analysis of retroperitoneal laparoscopic selective renal artery branch occlusion and nephron sparing surgery for ≥T1b stage renal carcinoma. Zhonghua Yi Xue Za Zhi. 2021;101(48):3961–3965. 10.3760/cma.j.cn112137-20210630-01479. [Abstract] [Google Scholar]
15. Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, et al. Comparisons of surgical outcomes between transperitoneal and retroperitoneal approaches in robot-assisted laparoscopic partial nephrectomy for lateral renal tumors:a propensity score-matched comparative analysis. J Robot Surg. 2021;15(1):99–104. 10.1007/s11701-020-01086-3. [Abstract] [Google Scholar]
16. Lanzotti NJ, Felice M, Janakiraman S, Lewer O, James C, Ellis JL, et al. Robotic transperitoneal versus retroperitoneal approach for anterior renal mass nephron-sparing surgery. J Robot Surg. 2024;18(1):75. 10.1007/s11701-023-01798-2. [Europe PMC free article] [Abstract] [Google Scholar]
17. Tang H, Shen T, Zhou K, Xu F, Lv H, Ge J. Retrospective comparison of clinical outcomes of robotic-assisted laparoscopic partial nephrectomy through transabdominal or retroperitoneal approaches in patients with T1b renal tumor. BMC Urol. 2022;22(1):208. 10.1186/s12894-022-01162-w. [Europe PMC free article] [Abstract] [Google Scholar]
18. Yin H, Zhou Z, Liu Q, Qiu F. Laparoscopic radical resection for large-volume renal carcinoma:via retroperitoneal or transperitoneal approach? J BUON. 2021;26(3):1094–1101. [Abstract] [Google Scholar]
19. Xu P, Luo J, Shuai H, Cai T, Cui S, Zhou L, et al. Comparison of the perioperative outcomes of robot-assisted laparoscopic transperitoneal versusretraperitoneal partial nephrectomy for posterior-lateral renal tumors:a systematic review and meta-analysis. J Robot Surg. 2024;18(1):186. 10.1007/s11701-024-01963-1. [Abstract] [Google Scholar]
20. Maurice MJ, Kaouk JH, Ramirez D, Bhayani SB, Allaf ME, Rogers CG, et al. Robotic Partial Nephrectomy for Posterior Tumors Through a Retroperitoneal Approach Offers Decreased Length of Stay Compared with the Transperitoneal Approach:A Propensity-Matched Analysis. J Endourol. 2017;31(2):158–162. 10.1089/end.2016.0603. [Abstract] [Google Scholar]
21. Paulucci DJ, Beksac AT, Porter J, Abaza R, Eun DD, Bhandari A, et al. A Multi-Institutional Propensity Score Matched Comparison of Transperitoneal and Retroperitoneal Partial Nephrectomy for cT1 Posterior Tumors. J Laparoendosc Adv Surg Tech A. 2019;29(1):29–34. 10.1089/lap.2018.0313. [Abstract] [Google Scholar]
22. Mendes G, Madanelo M, Vila F, Versos R, Teixeira BL, Rocha MA, et al. Transperitoneal vs. Retroperitoneal Approach in Laparoscopic Partial Nephrectomy for Posterior Renal Tumors:A Retrospective, Multi-Center, Comparative Study. J Clin Med. 2024;13(3):701. 10.3390/jcm13030701. [Europe PMC free article] [Abstract] [Google Scholar]
23. Ferakis N, Katsimantas A, Charalampogiannis N, Paparidis S, Rassweiler JJ, Gozen AS. Transperitoneal and retroperitoneal approach in laparoscopic partial nephrectomy for posterior cT1 renal tumors:A retrospective, two-centers, comparative study. Arch Ital Urol Androl. 2020;92(3) 10.4081/aiua.2020.3.230. [Abstract] [Google Scholar]
24. Kim HY, Lee DS, Yoo JM, Lee JH, Lee SJ. Retroperitoneal Laparoscopic Radical Nephrectomy for Large (>7?cm) Solid Renal Tumors:Comparison of Perioperative Outcomes with the Transperitoneal Approach. J Laparoendosc Adv Surg Tech A. 2017;27(4):393–397. 10.1089/lap.2016.0689. [Abstract] [Google Scholar]

Articles from Pakistan Journal of Medical Sciences are provided here courtesy of Professional Medical Publications